Aurisco Pharmaceutical Co Ltd Class A 605116
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 24.29
- Day Range
- CNY 23.90–24.29
- 52-Week Range
- CNY 17.33–27.58
- Bid/Ask
- CNY 24.05 / CNY 24.06
- Market Cap
- CNY 9.77 Bil
- Volume/Avg
- 913,924 / 1.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- 40.86
- Price/Sales
- 7.61
- Dividend Yield (Trailing)
- 0.66%
- Dividend Yield (Forward)
- 0.66%
- Total Yield
- 0.66%
Company Profile
Aurisco Pharmaceutical Co Ltd is engaged in production and sales of specialty APIs and pharmaceutical intermediates. The company's products include API's and Intermediates. Its products are supplied to Asia, Europe, America and Middle East through a well-established sales network.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 1,355
- Website
- http://www.aurisco.com
Comparables
Valuation
|
Metric
|
605116
|
300497
|
600521
|
|---|---|---|---|
Price/Earnings (Normalized) | 40.86 | — | 24.49 |
Price/Book Value | 4.80 | 2.71 | 3.11 |
Price/Sales | 7.61 | 4.18 | 2.90 |
Price/Cash Flow | 24.96 | 63.17 | 9.40 |
Price/Earnings
605116
300497
600521
Financial Strength
|
Metric
|
605116
|
300497
|
600521
|
|---|---|---|---|
Quick Ratio | 1.69 | 1.09 | 0.81 |
Current Ratio | 2.77 | 1.48 | 1.33 |
Interest Coverage | 129.49 | −3.82 | 6.22 |
Quick Ratio
605116
300497
600521
Profitability
|
Metric
|
605116
|
300497
|
600521
|
|---|---|---|---|
Return on Assets (Normalized) | 12.61% | −3.63% | 5.62% |
Return on Equity (Normalized) | 16.02% | −6.86% | 13.24% |
Return on Invested Capital (Normalized) | 14.91% | −3.45% | 7.70% |
Return on Assets
605116
300497
600521
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Ltschhzqz | Xgw | $586.5 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Fjzjfwls | Cdgfpdh | $110.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Ybqgmbvc | Wcbwljm | $107.6 Bil | |
MRNA
| Moderna Inc | Rybcvympy | Smx | $48.2 Bil | |
BNTX
| BioNTech SE ADR | Jjkzczlg | Zlrc | $22.2 Bil | |
ARGX
| argenx SE ADR | Wthclhqx | Lzyq | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Zvbflym | Rmjqflv | $19.0 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Fxqjvzndp | Gbdzzq | $15.1 Bil | |
INCY
| Incyte Corp | Cyxzqgrk | Mwdbnx | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Lbpcrvvys | Qntndc | $12.7 Bil |